Henric Bjarke
2021
In 2021, Henric Bjarke earned a total compensation of $1.4M as Senior Vice President and Chief Operating Officer at Inozyme Pharma, a 25% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $149,925 |
---|---|
Option Awards | $755,981 |
Salary | $440,955 |
Other | $6,798 |
Total | $1,353,659 |
Bjarke received $756K in option awards, accounting for 56% of the total pay in 2021.
Bjarke also received $149.9K in non-equity incentive plan, $441K in salary and $6.8K in other compensation.
Rankings
In 2021, Henric Bjarke's compensation ranked 7,661st out of 12,415 executives tracked by ExecPay. In other words, Bjarke earned more than 38.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,661 | 38th |
Manufacturing | 3,372 | 39th |
Chemicals And Allied Products | 1,490 | 37th |
Drugs | 1,324 | 37th |
Pharmaceutical Preparations | 978 | 37th |
Bjarke's colleagues
We found three more compensation records of executives who worked with Henric Bjarke at Inozyme Pharma in 2021.